These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8524104)

  • 1. Purification of recombinant Ras GTPase-activating proteins.
    Bollag G; McCormick F
    Methods Enzymol; 1995; 255():21-30. PubMed ID: 8524104
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of full-length neurofibromin: tubulin inhibits Ras GAP activity.
    Bollag G; McCormick F; Clark R
    EMBO J; 1993 May; 12(5):1923-7. PubMed ID: 8491185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of baculovirus-produced Rap1 GTPase-activating protein.
    Rubinfeld B; Polakis P
    Methods Enzymol; 1995; 255():31-8. PubMed ID: 8524116
    [No Abstract]   [Full Text] [Related]  

  • 4. Purification of baculovirus-expressed human Sos1 protein.
    Frech M; Cussac D; Chardin P; Bar-Sagi D
    Methods Enzymol; 1995; 255():125-9. PubMed ID: 8524094
    [No Abstract]   [Full Text] [Related]  

  • 5. Purification and GTPase-activating protein activity of baculovirus expressed p190.
    Settleman J; Foster R
    Methods Enzymol; 1995; 256():105-13. PubMed ID: 7476422
    [No Abstract]   [Full Text] [Related]  

  • 6. Purification of baculovirus-expressed recombinant Ras and Rap proteins.
    Porfiri E; Evans T; Bollag G; Clark R; Hancock JF
    Methods Enzymol; 1995; 255():13-21. PubMed ID: 8524096
    [No Abstract]   [Full Text] [Related]  

  • 7. Purification, characterization, and western blot analysis of human GTPase-activating protein from native and recombinant sources.
    Halenbeck R; Crosier WJ; Clark R; McCormick F; Koths K
    J Biol Chem; 1990 Dec; 265(35):21922-8. PubMed ID: 2123878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody against neurofibromatosis type 1 gene product reacts with a triton-insoluble GTPase activating protein toward ras p21.
    Hattori S; Ohmi N; Maekawa M; Hoshino M; Kawakita M; Nakamura S
    Biochem Biophys Res Commun; 1991 May; 177(1):83-9. PubMed ID: 1904223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of a transition-state analog of the Ras GTPase reaction by Ras-GDP, tetrafluoroaluminate, and GTPase-activating proteins.
    Mittal R; Ahmadian MR; Goody RS; Wittinghofer A
    Science; 1996 Jul; 273(5271):115-7. PubMed ID: 8658179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of Ras and GTPase-activating protein interactions by kinetic competition assay.
    Schaber MD; Gibbs JB
    Methods Enzymol; 1995; 255():171-8. PubMed ID: 8524101
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential regulation of neurofibromin and p120 GTPase-activating protein by nutritionally relevant fatty acids.
    Golubić M; Harwalkar JA; Bryant SS; Sundaram V; Jove R; Lee JH
    Nutr Cancer; 1998; 30(2):97-107. PubMed ID: 9589427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural analysis of the Ras GTPase activating protein catalytic domain by semirandom mutagenesis: implications for a mechanism of interaction with Ras-GTP.
    Hettich L; Marshall M
    Cancer Res; 1994 Oct; 54(20):5438-44. PubMed ID: 7923177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1.
    Klose A; Ahmadian MR; Schuelke M; Scheffzek K; Hoffmeyer S; Gewies A; Schmitz F; Kaufmann D; Peters H; Wittinghofer A; Nürnberg P
    Hum Mol Genet; 1998 Aug; 7(8):1261-8. PubMed ID: 9668168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of yeast two-hybrid system to evaluate Ras interactions with neurofibromin-GTPase-activating protein.
    Poullet P; Tamanoi F
    Methods Enzymol; 1995; 255():488-97. PubMed ID: 8524136
    [No Abstract]   [Full Text] [Related]  

  • 15. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21.
    Martin GA; Viskochil D; Bollag G; McCabe PC; Crosier WJ; Haubruck H; Conroy L; Clark R; O'Connell P; Cawthon RM
    Cell; 1990 Nov; 63(4):843-9. PubMed ID: 2121370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic properties, tissue and intracellular distribution of neurofibromin.
    Golubić M; Roudebush M; Dobrowolski S; Wolfman A; Stacey DW
    Oncogene; 1992 Nov; 7(11):2151-9. PubMed ID: 1437143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural analysis of the GAP-related domain from neurofibromin and its implications.
    Scheffzek K; Ahmadian MR; Wiesmüller L; Kabsch W; Stege P; Schmitz F; Wittinghofer A
    EMBO J; 1998 Aug; 17(15):4313-27. PubMed ID: 9687500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cDNA cloning and chromosomal mapping of a novel human GAP (GAP1M), a GTPase-activating protein of Ras.
    Li S; Satoh H; Watanabe T; Nakamura S; Hattori S
    Genomics; 1996 Aug; 35(3):625-7. PubMed ID: 8812506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning of a cDNA coding for neurofibromatosis type 1 protein isoform lacking the domain related to ras GTPase-activating protein.
    Suzuki H; Takahashi K; Kubota Y; Shibahara S
    Biochem Biophys Res Commun; 1992 Sep; 187(2):984-90. PubMed ID: 1339276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of neurofibromin and p120 GTPase activating protein (GAP) by dietary fatty acids.
    Lee JH; Harwalkar JA; Bryant SS; Sundaram V; Jove R; Golubic M
    Adv Exp Med Biol; 1999; 469():391-8. PubMed ID: 10667358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.